Samuel Whiting Insider Profile

4 Followers
Samuel Whiting, CMO at Tempest Therapeutics, holds 9.57K shares in Tempest Therapeutics (Ticker: TPST).
tipranks
Samuel Whiting

Samuel Whiting
Tempest Therapeutics (TPST)
CMO

Not Ranked
Samuel Whiting has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$9K
100.00%
A breakdown of Samuel Whiting's holdings

Insider Roles

Tempest Therapeutics
(TPST)
CMO
Roles that Samuel Whiting holds in companies

Most Profitable Insider Trade

Stock:
Tempest Therapeutics
(TPST)
Rating:Informative Buy
Date:Jan 10, 2022 - Jan 10, 2023
Return:-70.00%
The most profitable trade made by Samuel Whiting

Samuel Whiting's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Tempest Therapeutics
Jul 03, 2024
CMO
Uninformative Buy
9.95K
$8.70K
Success Rate for
TPST
0 out of 1 profitable transactions on
TPST
0%
Average Return for
TPST
Average return per transaction on
TPST
-70.00%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jun 30, 2021
Uninformative Buy
$0.00
-
$0.00
Jul 03, 2024
Uninformative Buy
$9.95K
-
$2.13
Jan 10, 2022
Informative Buy
$8.16K
-
$4.80
-70.00%
List of latest transactions for each holding click on a transaction to see Samuel Whiting's performance on stock

Samuel Whiting insider profile FAQ

What is the percentage of profitable transactions made by Samuel Whiting?
The percentage of profitable transactions made by Samuel Whiting is ―.
    What is the average return per transaction made by Samuel Whiting?
    The average return per transaction made by Samuel Whiting is ―.
      What stocks does Samuel Whiting hold?
      Samuel Whiting holds: TPST stocks.
        What was Samuel Whiting’s latest transaction?
        Samuel Whiting latest transaction was an Uninformative Buy of $9.95K.
          What was Samuel Whiting's most profitable transaction?
          Samuel Whiting’s most profitable transaction was an Informative Buy of TPST stock on January 10, 2022. The return on the trade was -70.00%.
            What is Samuel Whiting's role in Tempest Therapeutics?
            Samuel Whiting's role in Tempest Therapeutics is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.